Stryker Corp clears weekly gain, shares extend June rebound
Published on 06/28/2026 at 09:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-28, 09:49.
Stryker Corp. (US8636671013) closed the latest NYSE session with a weekly plus after a strong Friday move. The orthopaedics and medtech specialist added more than 5 percent on June 26, according to MarketBeat price data.MarketBeat overview for Stryker
What the numbers show
For the session dated June 26, 2026, Stryker shares finished at 332.31 US dollars, up 16.20 dollars or 5.12 percent versus the prior close, per MarketBeat.MarketBeat price history The trading range spanned from an intraday low at 317.75 dollars to a high at 333.82 dollars on the NYSE.
Extended trading after the bell showed a modest continuation, with the shares quoted at 333.20 dollars, 0.27 percent above the official close. A separate forecast aggregation at PandaForecast cites a current value around 332.71 dollars and highlights a recent positive session for Stryker with a volume figure near 5.5 million shares.
Sector context for the week
Stryker is a constituent of the S&P 500 healthcare segment, where medtech names such as Zimmer Biomet and Medtronic provide a natural peer comparison. During the same late-June period, broader Wall Street commentary pointed to pressure on technology and energy names while the Dow displayed resilience, underlining the relative stability of diversified healthcare holdings.PandaForecast market summary
On German platforms, Stryker’s listing is tracked via its ISIN with indicative prices near 291 euros, reflecting currency translation from the NYSE level and typical spreads on Frankfurt-linked trading services. The company remains categorized under medical devices and equipment, a sector that investors often see as structurally supported by demographic trends and procedure volumes.
More data and news on the Stryker Corp. shares
Historical prices, regulatory filings and further corporate updates on Stryker Corp. can be found in the dedicated topic section and on the company’s Investor Relations page.
The product behind the stock
Stryker generates a large share of its revenue from orthopaedic implants and surgical equipment, including hip and knee replacement systems. In Europe, the group recently expanded its trauma portfolio with the Pangea plating system platform, adding fixation options for complex fractures in the region.Finance Yahoo coverage of Pangea launch
Where the stock trades today
The Stryker Corp. shares (US8636671013) last closed on the NYSE on 2026-06-26 at 332.31 US dollars, with an after-hours indication at 333.20 US dollars as of 19:45 Eastern Time.
Key data on the Stryker Corp. shares
- Company: Stryker Corporation
- ISIN: US8636671013
- WKN: 864952
- Ticker: SYK
- Trading venue: NYSE
- Price (as of 2026-06-26, 19:45): 333.20 USD
- Market cap: 126 billion USD (as of 2026-06-26)
- Sector / industry: Health Care Equipment & Supplies
- Index membership: S&P 500
- Next earnings date: 2026-07-25
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. All data are based on sources believed to be reliable at the time of publication but may change without notice.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
